Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images.
Kang ZhangXiaohong LiuJie XuJin YuanWenjia CaiTing ChenKai WangYuanxu GaoSheng NieXiaodong XuXiaoqi QinYuandong SuWenqin XuAndrea OlveraKanmin XueZhihuan LiMeixia ZhangXiaoxi ZengCharlotte L ZhangOulan LiEdward E ZhangJie ZhuYiming XuDaniel KermanyKaixin ZhouYing PanShaoyun LiIat Fan LaiYing ChiChanguang WangMichelle PeiGuangxi ZangQi ZhangJohnson LauDennis LamXiaoguang ZouAizezi WumaierJianquan WangYin ShenFan Fan HouPing ZhangTao XuYong ZhouGuangyu WangPublished in: Nature biomedical engineering (2021)
Regular screening for the early detection of common chronic diseases might benefit from the use of deep-learning approaches, particularly in resource-poor or remote settings. Here we show that deep-learning models can be used to identify chronic kidney disease and type 2 diabetes solely from fundus images or in combination with clinical metadata (age, sex, height, weight, body-mass index and blood pressure) with areas under the receiver operating characteristic curve of 0.85-0.93. The models were trained and validated with a total of 115,344 retinal fundus photographs from 57,672 patients and can also be used to predict estimated glomerulal filtration rates and blood-glucose levels, with mean absolute errors of 11.1-13.4 ml min-1 per 1.73 m2 and 0.65-1.1 mmol l-1, and to stratify patients according to disease-progression risk. We evaluated the generalizability of the models for the identification of chronic kidney disease and type 2 diabetes with population-based external validation cohorts and via a prospective study with fundus images captured with smartphones, and assessed the feasibility of predicting disease progression in a longitudinal cohort.
Keyphrases
- deep learning
- end stage renal disease
- chronic kidney disease
- type diabetes
- diabetic retinopathy
- peritoneal dialysis
- convolutional neural network
- blood glucose
- optical coherence tomography
- blood pressure
- glycemic control
- newly diagnosed
- artificial intelligence
- cardiovascular disease
- body mass index
- insulin resistance
- physical activity
- risk factors
- adipose tissue
- patient reported outcomes
- adverse drug